TrialEuropean journal of heart failure2025

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.

Mahir Karakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.